Date
|
Title
|
30.11.2014
|
Launch DnBiolab, Malaga, Spain
|
07.11.2014
|
EMERGING Medical Technolgies Summit, San Francisco Bay, November 11-12, 2014, USA |
03.11.2014
|
BIO-Europe is Europe's largest partnering conference serving the globalbiotechnology industry, 2014 |
09.10.2014
|
ENTENTE LifeSciences-Investment Forum will tahe place in Brussels on October 9,2014 Belgium |
07.10.2014
|
SEMICON Europa 2014 (October 7-9 2014), Grenoble, France |
24.09.2014
|
BIOPHARM America 2014 Boston, MA, USA |
23.09.2014
|
European Food Venture Forum September 23&24, 2014
|
23.06.2014
|
HTS Healthtech Summit will return to Lausanne on June 23&24, 2014
|
27.05.2014
|
MOBIP Pan European Partnership and Investment for Mobile
Services, Thessaloniki, Grece
|
22.05.2014
|
32 Technology companies selected to showcase at VENTURE4i, Grenoble-Alpes - 22 May 2014, France
|
27.02.2014
|
EMMINVEST European enterpreneurship promotional program, Berlin, Germany
|
15.10.2013
|
Launch DnBiomed, Spain
|
05.09.2013
|
EFVF European Food Venture Forum 05.-06. September 2013, Aarhus, Denmark
|
05.02.2013
|
Sales preparations USA, Begin 1st September 2013
|
01.02.2013
|
indiegogo, CA, USA
|
04.07.2012 |
SEF-Swiss Start-Up Award,
Zurich |
19.03.2012 |
3rd pat.pend. preceded by the 1st
CH684982 patent; 2nd CH706255 (A2); PCT-WO2012-xxxxxxxxx pat.pend. |
21.11.2011 |
Clinical-trials.gov; NCT00407420
(Bristol Royal
Hospital,UK)/ (Dr. Per Sodersten, PhD, Karolinska
Institutet, Stockholm; FDA clearance |
17.08.2011 |
Internet presence |
15.11.2010 |
2nd pat.pend. preceded by the 1st
CH684982 patent; CH701039 (A2); PCT-WO2009-xxxxxxxxx pat.pend. |
01.11.2010 |
Venturekick &
Venturelab 2010 planning and training
stages |
20.06.2010 |
Marketing
and PR
concept created by Partner
Company, May /
June 201 |
15.06.2010 |
10
fully functional products
available which are in test use since
June 2010 |
01.01.2009 |
Business and personal preparations; project design, realizations, development and strategy |
01.01.2008 |
Start and business dispositions of "Erib
Corp." |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|